Ileitis Symposium during the IPVS in Copenhagen
COPENHAGEN - Boehringer Ingelheim is proud to announce the 2nd Boehringer Ingelheim IPVS Ileitis symposium during the IPVS 2006 congress in Copenhagen.

Enterisol® Ileitis approved in Australia - first live swine vaccine ever in this market
AUSTRALIA - Boehringer Ingelheim Animal Health GmbH, announced today that the Australian regulatory authorities have granted market authorization for the porcine live vaccine Enterisol® Ileitis. Enterisol® Ileitis has been approved for the active immunization...

Boehringer Donates PRRS Risk Assessment Program To Industry
US - Boehringer Ingelheim Vetmedica, Inc., last week transferred ownership of its Risk Assessment Program for porcine reproductive and respiratory syndrome (PRRS) to the American Association of swine Veterinarians (AASV).

New Research Program Targets Porcine Circovirus
US - Porcine Circovirus Associated Diseases (PCVAD) such as PMWS and PDNS have been wreaking havoc in Europe for a number of years now, and are becoming a growing threat to the North American industry. In an effort to share information on the subject,...

Swine practice: Marked increase in performance after ileitis vaccination
EU - Since the launch of Boehringer's ileitis vaccine "Enterisol® Ileitis" in most European countries from September to November 2005, the oral ileitis vaccine has very quickly become firmly established in health maintenance and performance enhancement...

Four million piglets benefit from oral ileitis vaccine
GERMANY - More than 4 million doses of Enterisol® Ileitis, the oral ileitis vaccine, have been supplied to German vets since the vaccine was launched in December 2004, said a spokesman for Boehringer...

New Ileitis vaccine produces dramatic performance lift, helps PMWS
EU - In just four months, the use of a vaccine to control ileitis in a 550-sow herd has increased piglets’ average daily weight gain by 35%, cut mortality by more than 60% and improved the uniformity of carcase weights, leading to better prices. It has...

2006 PRRS Research Awards from BIVI Focus on Detection, Diagnostic Protocols
MISSOURI - Research studies involving the transmission and monitoring of Porcine Reproductive and Respiratory Syndrome (PRRS) are the areas of concentration for the 2006 Advancement in PRRS Research Awards sponsored by Boehringer Ingelheim Vetmedica,...

Boehringer Ingelheim offers combination discount for oral vaccines in USA
USA – Boehringer Ingelheim Vetmedica, Inc., (BIVI) have announced in the US they are offering a 20 percent discount from the list price on all orders of Ingelvac® ERY-ALC for control of swine erysipelas, when shipped with an equal dose amount of Enterisol®...

Boehringer Ingelheim Expands Swine Team
US - Boehringer Ingelheim Vetmedica, Inc., (BIVI) announces the promotion of Sara Balvanz to sales representative and the addition of Abby Lauenroth as corporate account trainer for the company’s swine division.

Boehringer Ingelheim now markets nutraceuticals in the USA
US - Ingelheim/Germany, Copenhagen/Denmark, 13 January 2006 – Boehringer Ingelheim’s Natural Care Center (NCC) announced today that it will also be marketing two of its recent nutraceutical products in the United States: Diaque®, an oral rehydration supplement...

Boehringer Ingelheim Adds Two to Swine Sales Team
MISSOURI - Boehringer Ingelheim Vetmedica, Inc., (BIVI) announces the addition of Chris Beard and Douglas Skartvedt as sales representatives for the company’s swine division. Both have more than 10 years of swine health sales and production experien...

Boehringer Ingelheim Offers PRRS Profiling In The New Year
MISSOURI - Boehringer Ingelheim Vetmedica, Inc. (BIVI) is offering swine producers diagnostic profiling services to protect pigs from porcine reproductive and respiratory syndrome (PRRS).

First vaccine for the control of porcine Ileitis now available across Europe
GERMANY - Boehringer Ingelheim Animal Health GmbH, have announced the pan-European launch of Enterisol® Ileitis, the first enteric vaccine to have received marketing authorization in the EU to improve pig’s weight gain and to reduce body weight variability....

Study reveals the value of vaccination
UK - Just over eighteen months ago, Boehringer Ingelheim's Ingelvac M hyo vaccine hit the UK and Irish markets. This innovative product delivered a new immunity to enzootic pneumonia through a single shot administration and has been used by vets and...

Label extensions for Boehringer Ingelheim Animal Health`s Swine Vaccines
GERMANY - Boehringer Ingelheim Animal Health has received two important label extensions from health care authorities for the vaccines Ingelvac® PRRS MLV and Ingelvac® M.hyo, which reflects the company’s efforts to strengthen and improve its swine vaccines...